|
Market Closed -
Euronext Bruxelles
11:55:00 2026-09-07 EDT
|
After hours 12:32:43 | |||
| 210.30 EUR | -0.14% |
|
210.20 | -0.05% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
EPS & Dividend: UCB
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 1.3 | 1.33 | 1.36 | 1.39 | 1.45 | 1.457 | 1.502 | 1.534 |
| Rate of return | 1.3% | 1.81% | 1.72% | 0.72% | 0.61% | 0.69% | 0.71% | 0.73% |
| EPS 2 | 5.6 | 2.2 | 1.76 | 5.61 | 8.2 | 10.01 | 12.13 | 14.74 |
| Distribution rate | 23.2% | 60.5% | 77.3% | 24.8% | 17.7% | 14.5% | 12.4% | 10.4% |
| Reference price 2 | 100.35 | 73.56 | 78.90 | 192.20 | 238.60 | 210.60 | 210.60 | 210.60 |
| Nbr of stocks (in thousands) | 188,812 | 189,959 | 189,721 | 189,720 | 189,996 | 190,663 | - | - |
| Announcement Date | 2/24/22 | 2/22/23 | 2/28/24 | 2/27/25 | 2/24/26 | - | - | - |
1EUR in Million2EUR
Estimates
Past dividends: UCB
| 2026-05-04 | Ex-dividend date - 1.015 EUR | 00:00 |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 0.69% | 0.71% | 21.03x | 3.33x | 4.65x | |
| 0.47% | 0.54% | 19.17x | 2.52x | 4.48x | |
| 2.39% | 2.53% | 20.62x | 3.73x | 4.39x | |
| -.--% | -.--% | -17.31x | 9.97x | 25.92x | |
| -.--% | -.--% | 35.25x | 7.26x | 12x | |
| -.--% | -.--% | 38.13x | 1.77x | 3.6x | |
| -.--% | -.--% | 56.56x | 4.33x | 3.61x | |
| -.--% | -.--% | 68.2x | 6.95x | 7.25x | |
| -.--% | -.--% | 23.84x | 3.5x | 5.11x | |
| 0.16% | 0.19% | 67.45x | 27.78x | 41.69x | |
| Average | 0.37% | 0.4% | 33.29x | 7.11x | 11.27x | |
| Weighted average by Cap. | 0.53% | 0.57% | 24.89x | 5.68x | 9.85x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
- Stock Market
- Stocks
- UCB Stock
- Valuation UCB
- Dividend
Select your edition
All financial news and data tailored to specific country editions
